Study: Lp(a) Testing Would Save Both Lives and Dollars
Posted5 months agoActive5 months ago
sciencedirect.comResearchstory
supportivepositive
Debate
0/100
Lp(a) TestingHeart Disease PreventionMedical Cost-Effectiveness
Key topics
Lp(a) Testing
Heart Disease Prevention
Medical Cost-Effectiveness
A study found that widespread Lp(a) testing could save lives and dollars by identifying high-risk heart disease patients.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
3m
Peak period
1
0-1h
Avg / period
1
Key moments
- 01Story posted
Aug 20, 2025 at 10:44 AM EDT
5 months ago
Step 01 - 02First comment
Aug 20, 2025 at 10:48 AM EDT
3m after posting
Step 02 - 03Peak activity
1 comments in 0-1h
Hottest window of the conversation
Step 03 - 04Latest activity
Aug 20, 2025 at 10:48 AM EDT
5 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 44962436Type: storyLast synced: 11/18/2025, 1:45:16 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
This study shows an exception to that rule -- testing Lp(a), the strongest hereditary biomarker of heart disease risk.
This study simulated the effects of wide-spread Lp(a) testing on a sample of 10,000 patients in two countries (UK and Australia). They found 1,807 people would have had modified treatment, gaining 217-255 quality-adjusted life years. (Quality-adjusted life years are used by the NHS in the UK to make policy decisions.)
Furthermore, they found there would be an overall cost savings, since Lp(a) testing itself is cheap and it prevents heart attacks and strokes (which are expensive to treat).
It's really rare in medicine to find an "obvious win" like this.